Subscribe

What are you looking for?

Main Menu

明報新聞網

康希諾生物曾升逾24% 與德普世生物達成mRNA治療型腫瘤疫苗戰略合作

Future Wealths
Future Wealths
26 8 月, 2026
One Min Read
1 Views
0 Comments
康希諾生物(6185)曾升逾24%，公司早前於微信公布，與德普世生物達成mRNA治療型腫瘤疫苗戰略合作。

原文: https://finance.mingpao.com/fin/instantf/20260826/1787713038506/%E5%BA%B7%E5%B8%8C%E8%AB%BE%E7%94%9F%E7%89%A9%E6%9B%BE%E5%8D%87%E9%80%BE24-%E8%88%87%E5%BE%B7%E6%99%AE%E4%B8%96%E7%94%9F%E7%89%A9%E9%81%94%E6%88%90mrna%E6%B2%BB%E7%99%82%E5%9E%8B%E8%85%AB%E7%98%A4%E7%96%AB%E8%8B%97%E6%88%B0%E7%95%A5%E5%90%88%E4%BD%9C%22%20target=%22blank

Last Update: 26 8 月, 2026

Please share this article if you like it!

Link Copied!
Future Wealths
Written By

Future Wealths

Other Articles

Related Posts

Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.

Accept